Mutated or methylated Gene including FGFR3, TERT, TP53, ONECUT2, and age older than 50 showed a significant impact in evaluating UTUC risks (P-value < 0.01). This evidence concerns the gene FGFR3 and renal pelvis/ureter urothelial carcinoma.